ECSP10010661A - Dronedarona para la prevención de la cardioversión - Google Patents

Dronedarona para la prevención de la cardioversión

Info

Publication number
ECSP10010661A
ECSP10010661A EC2010010661A ECSP10010661A ECSP10010661A EC SP10010661 A ECSP10010661 A EC SP10010661A EC 2010010661 A EC2010010661 A EC 2010010661A EC SP10010661 A ECSP10010661 A EC SP10010661A EC SP10010661 A ECSP10010661 A EC SP10010661A
Authority
EC
Ecuador
Prior art keywords
dronedarone
cardioversion
prevention
drug
preparation
Prior art date
Application number
EC2010010661A
Other languages
English (en)
Inventor
Christophe Gaudin
Nacera Hamdani
Davide Radzik
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39739955&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP10010661(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ECSP10010661A publication Critical patent/ECSP10010661A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Furan Compounds (AREA)

Abstract

Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la cardioversión.
EC2010010661A 2008-06-10 2010-12-07 Dronedarona para la prevención de la cardioversión ECSP10010661A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6026008P 2008-06-10 2008-06-10
EP08290532A EP2133075A1 (en) 2008-06-10 2008-06-10 Use of dronedarone for the preparation of a medicament intended for the prevention of cardioversion

Publications (1)

Publication Number Publication Date
ECSP10010661A true ECSP10010661A (es) 2011-01-31

Family

ID=39739955

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010661A ECSP10010661A (es) 2008-06-10 2010-12-07 Dronedarona para la prevención de la cardioversión

Country Status (25)

Country Link
US (1) US20110166221A1 (es)
EP (2) EP2133075A1 (es)
JP (1) JP2011522875A (es)
KR (1) KR20110026421A (es)
CN (1) CN102056602A (es)
AR (1) AR072070A1 (es)
AU (1) AU2009259008A1 (es)
BR (1) BRPI0915015A2 (es)
CA (1) CA2727210A1 (es)
CL (1) CL2010001421A1 (es)
CO (1) CO6280478A2 (es)
CR (1) CR11755A (es)
DO (1) DOP2010000361A (es)
EA (1) EA201071412A1 (es)
EC (1) ECSP10010661A (es)
IL (1) IL209790A0 (es)
MA (1) MA32461B1 (es)
MX (1) MX2010013700A (es)
NI (1) NI201000212A (es)
PE (1) PE20110066A1 (es)
SV (1) SV2010003753A (es)
TW (1) TW201002314A (es)
UY (1) UY31887A (es)
WO (1) WO2009150534A1 (es)
ZA (1) ZA201009171B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
PE20091809A1 (es) 2008-04-17 2009-12-03 Sanofi Aventis Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2013024411A1 (en) 2011-08-12 2013-02-21 Lupin Limited Co-milled formulation of dronedarone
CN104721547A (zh) * 2015-03-14 2015-06-24 包汉雨 一种促进房颤患者复律的中药组合物

Also Published As

Publication number Publication date
TW201002314A (en) 2010-01-16
EP2303259A1 (en) 2011-04-06
CN102056602A (zh) 2011-05-11
DOP2010000361A (es) 2010-12-31
SV2010003753A (es) 2011-03-15
MX2010013700A (es) 2011-02-23
AR072070A1 (es) 2010-08-04
WO2009150534A1 (en) 2009-12-17
CL2010001421A1 (es) 2011-05-13
NI201000212A (es) 2011-04-27
CO6280478A2 (es) 2011-05-20
CA2727210A1 (en) 2009-12-17
ZA201009171B (en) 2012-03-28
UY31887A (es) 2010-01-29
EA201071412A1 (ru) 2011-06-30
AU2009259008A1 (en) 2009-12-17
PE20110066A1 (es) 2011-02-16
US20110166221A1 (en) 2011-07-07
CR11755A (es) 2011-01-10
IL209790A0 (en) 2011-02-28
MA32461B1 (fr) 2011-07-03
KR20110026421A (ko) 2011-03-15
JP2011522875A (ja) 2011-08-04
BRPI0915015A2 (pt) 2015-10-27
EP2133075A1 (en) 2009-12-16

Similar Documents

Publication Publication Date Title
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
NI201000211A (es) Dronedarona para la prevención de la fibrilación auricular permanente.
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI0919193A2 (pt) Uso de lipídeo, e, composição nutricional
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
NI201000172A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad.
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BRPI1010617A2 (pt) uso de uma composição, composição, uso não médico da composição, e, método para preprar uma composição.
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI1009757A2 (pt) composto, composição farmacêutica, e , uso de um composto.
ECSP10010661A (es) Dronedarona para la prevención de la cardioversión
CL2014003525A1 (es) Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension.
SV2011003827A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0916943A2 (pt) composição lubrificante, e, uso da mesma
BRPI1014125A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
BRPI0913297A2 (pt) composição, farmacêutica, uso de uma composição, e, kit terapêutico.
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”